首页    期刊浏览 2024年12月01日 星期日
登录注册

文章基本信息

  • 标题:Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology
  • 本地全文:下载
  • 作者:David X. Thomas ; Sumali Bajaj ; Kevin McRae-McKee
  • 期刊名称:Scientific Reports
  • 电子版ISSN:2045-2322
  • 出版年度:2020
  • 卷号:10
  • 期号:1
  • DOI:10.1038/s41598-020-71305-2
  • 出版社:Springer Nature
  • 摘要:Alzheimer’s disease patients typically present with multiple co-morbid neuropathologies at autopsy, but the impact of these pathologies on cognitive impairment during life is poorly understood. In this study, we developed cognitive trajectories for patients with common co-pathologies in the presence and absence of Alzheimer’s disease neuropathology. Cognitive trajectories were modelled in a Bayesian hierarchical regression framework to estimate the effects of each neuropathology on cognitive decline as assessed by the mini-mental state examination and the clinical dementia rating scale sum of boxes scores. We show that both TDP-43 proteinopathy and cerebral amyloid angiopathy associate with cognitive impairment of similar magnitude to that associated with Alzheimer’s disease neuropathology. Within our study population, 63% of individuals given the ‘gold-standard’ neuropathological diagnosis of Alzheimer’s disease in fact possessed either TDP-43 proteinopathy or cerebral amyloid angiopathy of sufficient severity to independently explain the majority of their cognitive impairment. This suggests that many individuals diagnosed with Alzheimer’s disease may actually suffer from a mixed dementia, and therapeutics targeting only Alzheimer’s disease-related processes may have severely limited efficacy in these co-morbid populations.
国家哲学社会科学文献中心版权所有